Category Archives: Investing

Canada: Want future job security? Take a college course on cannabis

Canada is legalizing recreational cannabis for adult use on October 17, so now would be the time to take a college course on cannabis.

With Canadian cannabis businesses offering sky-high wages in exchange for expertise, many are now looking for a reliable way to break into the industry. Prospective cannabis industry workers—and the businesses doing the hiring themselves—are now looking for academia to provide that bridge. Canada is preparing to officially legalize recreational cannabis for adult use on October 17. With the cannabis industry booming, businesses have begun teaming up with universities to expedite the implementation of college and university cannabis courses.

The cannabis company Sunniva, one of Canada’s licensed producers under the newly legal recreational cannabis legislation, has already partnered with Okanagan College in British Columbia.

The college recently created an advisory board in order to consult with legal cannabis companies like Sunniva directly, as to better inform their courses that train students to work in the cannabis industry. The courses offered to students range from programs on investment and trading, business, to cultivation and more.

While courses are often developed with governmental input, the cannabis industry is simply moving too fast. And as a new industry, cannabis businesses themselves are more experienced and can offer practical guidance. As thousands of new job opportunities crop up as a result of legalization, colleges need a way to keep up with the industry.

Cannabis companies are partnering with colleges1 Want Future Job Security? Take a College Course on Cannabis

This also stands to benefit both students who are looking for work within the cannabis industry and businesses that are seeking professionals to hire. As the CEO of Sunniva, Dr. Tony Holler, says in the Financial Post, cannabis businesses are currently forced to hire and train inexperienced employees themselves, which is both expensive and time-consuming.

Durham College in Ontario is also already offering a two-day course for business graduates to learn about medical cannabis, and this fall is rolling out a new specialization program in partnership with a subsidiary of Emblem Corp, a Canadian licensed cannabis producer. This program includes six courses, some of which require students to be at least 19 years old.

The Ontario college has also partnered with software company Ample Organics Inc, lab testing company Molecular Science Corp, recruitment company Cannabis at Work, and the publication CannaInvestor Magazine.

Niagara College is also now offering its own graduate certificate program for students who want to learn cannabis production, which was designed with the help of multiple licensed producers.

While this type of arrangement between cannabis companies and colleges is novel, so is the cannabis industry itself and the university courses needed to help it thrive.

To read more visit: https://420intel.com/articles/2018/10/04/canada-want-future-job-security-take-college-course-cannabis

Border Patrol agents prepare for legalization of recreational marijuana in Canada

Recreational marijuana will be legal in Canada starting Oct. 17.

Border Patrol agents say they are ready for heavier traffic, which can impact anyone going to Canada.

U.S. Customs and Border Protection Chief Officer Aaron Bowen warns anyone that may try to sneak weed back into the U.S. will face anything from a fine to a zero-tolerance policy.

“A smell is obviously going to alert an officer and probably going to get you a secondary exam because we want to make sure the actual marijuana isn’t in the vehicle,” Bowen says.

Medical marijuana will also be seized at the border.

Anyone who gets caught could be arrested and fined $500.

Agents urge people planning to use marijuana in Canada to spend the night or have a designated driver.

Weedcraft Inc. Is A Tycoon Simulator For Future Ganjapreneurs

Expect to play it in early 2019.

The cannabis industry is experiencing an all-time high when it comes to growth and acceptance for the plant that powers their business. Grassroots legalization efforts are happening all across the country, while surging stocks for cannabis companies, like Tilray, have reminded investors of the dotcom boom. Even politicians have turned heel, joining the Green Rush however they can.

Now you too can participate (from the comforts of your computer) thanks to a tycoon game-parody called Weedcraft Inc. Published by Devolver Digital, the game allows players the typical mechanics and systems found in a tycoon game, but wrapped in the specificity found in starting a marijuana business. Instead of a free-for-all sandbox experience, Weedcraft Inc. will follow a loose narrative, as players explore different vignettes of the cannabis start-up enterprise.

According to Alexander, the game will change based on the state and situation players find themselves in depending on the vignette. You can also play the game with varying degrees of morality and legality; bribing cops or building false storefronts to hide your cannabis farms is totally allowed. The line the game developers won’t cross? You won’t see any kids smoking weed on screen. The style in which you play the game will also affect whatever bonuses and abilities you’ll acquire.

“There are certain perks you can only get if you’re super shady,” Alexander said. “There are certain perks you can only get if you’re decent.”

“Right now, it’s like the end of Prohibition meets the Gold Rush,” Scott Alexander, the game’s main writer, told Polygon. “The federal illegality combined with the state-by-state legalization has created a financial morass and just a weird, interesting place. And we thought, ‘Well, that’s a tycoon game waiting to happen.’”

“Playing fully decent is like getting a cultural victory in Civilization,” he added. “[It’s like,] ‘Can I play the whole game without fucking anyone over?’”

According to Devolver Digital co-founder Mike Wilson, you can expect Weedcraft Inc. to debut in early 2019.

To read more visit: https://thefreshtoast.com/cannabis/weedcraft-inc-is-a-tycoon-simulator-for-future-ganjapreneurs/

Medical marijuana businesses given deadline to get licensed with state

LANSING, Mich. — The deadline for medical marijuana businesses to get a license from the state has changed, again.

Businesses now have until October 31 to get a license or face legal action from police or the state attorney general’s office.

This is the fourth time this year officials have changed the deadline.

Officials with the state’s Department of Licensing and Regulatory Affairs are trying to force businesses into a licensed system.

Last month, state officials tried to force nearly 100 medical marijuana businesses to close because they hadn’t submitted paperwork by the previous deadline of September 15.

In November, voters will decide whether or not recreational marijuana should be legal for adults in Michigan.

To read more visit: https://fox17online.com/2018/10/02/medical-marijuana-businesses-given-deadline-to-get-licensed-with-state/

Boston inches forward with recreational marijuana permits

Every two weeks, at meetings of the Massachusetts Cannabis Control Commission, marijuana officials display a map showing how many completed applications for recreational pot business licenses have been submitted from each county in the state.

Conspicuously lagging behind: Suffolk County, home to Boston — which, unlike most cities in the state that haven’t banned such companies, has yet to issue a local permit to a recreational marijuana operator.

Now, those numbers are poised to grow. Officials in the administration of Boston Mayor Martin J. Walsh told the Globe last week that the city will negotiate its first so-called “host community agreements” with marijuana companies in the first two weeks of October.

Those contracts are required in order to win a state license from the commission, so Walsh’s signature on one would allow that company to move forward at the state level. The deals typically call for payments from the company to the municipality and spell out other conditions, such as the facility’s hours of operation.

City Hall officials declined to put a timeline on when pot shops might open in Boston, however, saying it depends on when the state issues final licenses to applicants from the city. They also declined to make Walsh or other city leaders available for an on-the-record interview.

The officials also gave new details on how they would apply the city’s zoning rules, which require a half-mile buffer between licensed marijuana facilities. In several neighborhoods, two applicants are vying for permission to open in the same area, raising the question of how the city would choose between them.

The officials said those decisions will be made by the office of Alexis Tkachuk, the city’s director of emerging industries, in collaboration with the city’s transportation, planning, and legal departments.

Officials will consider a number of variables: which company applied first, the reaction of neighbors to each proposal, traffic impacts, how the proposal fits within the city’s development and planning schemes, and whether the company is eligible for state programs boosting entrepreneurs from communities disproportionately affected by the war on drugs.

Those variables, however, will not be weighted, and applicants won’t be assigned a score. Instead, officials will simply judge the “totality” of each application.

That behind-closed-doors process is unlikely to placate advocates and some city councilors, who have called on the city to enact more robust mandates favoring companies owned by minorities and local residents over wealthy out-of-state investors.

Shanel Lindsay, an attorney, businesswoman, and the cofounder of Equitable Opportunities Now, a group pushing for equity in the cannabis industry, slammed the city’s “opaque” process. She said the failure to create an objective standard and make decisions in public opens the door to bias and favoritism, and is likely to favor already-wealthy white operators who can afford to hire sophisticated lawyers and former city officials to grease the wheels.

“This is exactly what we were worried about,” Lindsay said. “It’s really vague and subjective. There’s no clear standard, no community collaboration, no transparency, and no clear acknowledgment of the necessity to make equity a prevailing favor in their decisions.”

City officials noted that every applicant must hold a public hearing and address neighborhood concerns. They also said they would consider waiving the half-mile buffer for applicants that qualify for the state commission’s equity programs, explaining that such entrepreneurs might apply later, after prime properties are taken and buffer zones have been drawn around facilities whose owners moved faster. The process for seeking such an accommodation is unclear, though.

Officials further stressed that Boston, unlike other municipalities, hasn’t categorically zoned marijuana businesses out of residential areas or off of main streets. They also pledged not to impose onerous conditions on or demand large payments from marijuana operators, saying the city’s host community agreements would mostly be focused on addressing concerns raised by neighbors — for example, agreeing not to install benches and picnic tables where people might hang out and smoke weed.

To read more visit: https://420intel.com/articles/2018/10/02/boston-inches-forward-recreational-marijuana-permits

US gov’t approve importation of pot drug for tremor study

SAN DIEGO — In a rare move, the US government has approved the importation of marijuana extracts from Canada for a clinical trial, highlighting a new avenue for American researchers who have long had trouble obtaining the drug for medical studies.

The University of California San Diego’s Center for Medicinal Cannabis Research announced Tuesday the Drug Enforcement Administration has OK’d its plans to import capsules containing two key cannabis compounds — CBD and THC — from British Columbia-based Tilray Inc . to study their effectiveness in treating tremors that afflict millions of people, especially those over 65.

Marijuana remains illegal under federal law, and researchers aren’t allowed to simply obtain it through providers licensed under state law. The US has a program for supplying it for research through the National Institute on Drug Abuse, with cannabis grown by the University of Mississippi, but scientists have long complained about the difficulty of obtaining it, as well as the quality and limited variety of the pot available.

The University of California San Diego researchers spent years planning and seeking approval for their study from the DEA and the Food and Drug Administration. Paul Armentano, deputy director of the marijuana law reform organization NORML, said that illustrated how badly American researchers need alternative sources for cannabis.

“It’s very telling that you have researchers in the U.S. willing to exert the patience and go through the regulatory hurdles to make this happen at the same time the United States has its own domestic supply source,” Armentano said.

Medical marijuana is federally legal in Canada, and the country will allow recreational sale and use beginning next month.

Marijuana compounds have been imported for clinical trials before, including by Britain-based GW Pharmaceuticals, which won approval this year to sell its purified CBD capsule, Epidiolex, to treat severe forms of epilepsy — the first cannabis drug approved by the US Food and Drug Administration. While GW Pharmaceuticals developed that drug in-house before bringing it to the US for testing, Tilray, which recently became the first marijuana company to complete an initial public stock offering in the US, said it can work with researchers to develop the cannabis formulations they hope to study.

“It’s a really big milestone for Tilray and also just for the whole industry,” said Catherine Jacobson, Tilray’s director of clinical research. “Researchers in the U.S. have really been limited to doing research using dried flower. We have been able to prove to the FDA that we can manufacture investigational study drugs containing cannabinoids that meet their standards.”

Neither the FDA nor the DEA had immediate details on how often the agencies have approved the import or use of foreign-made cannabis drugs in research, but DEA spokeswoman Katherine Pfaff says: “It is done. There are definitely situations where, when there’s no source in the U.S., a registrant can import a cannabis-derived drug from another country.”

The National Institute on Drug Abuse usually provides marijuana as bulk flower or joints to be vaporized or smoked.
NIDA, which does intend to expand how much marijuana the University of Mississippi grows for research, does not yet provide marijuana compounds in capsules, said Don Stanford, assistant director of the Research Institute of Pharmaceutical Sciences at the university.

Researchers say it’s tough to measure the dose someone receives when they inhale pot. Dr. Fatta Nahab, a neurologist at the University of California San Diego Health’s Movement Disorder Center, is the principal investigator on the tremor study. He said he worried that the seniors he expected to recruit as participants wouldn’t want to inhale marijuana, and the researchers have spent the past two years on paperwork and regulatory hurdles to obtain the capsules.

There is no specific drug to treat essential tremor, a shaking condition. Unlike Parkinson’s disease, which causes shaking when someone is not moving, people with essential tremors shake when they are, making everyday activities like writing, drinking and speaking difficult. The condition afflicts 10 million people nationally and millions more across the globe, according to the International Essential Tremor Foundation.

Many patients try to control the shaking by repurposing other drugs, such as blood pressure medicine, with limited success.

“There is a huge need to come up with something,” Nahab said.

Nahab said he started looking into whether marijuana could be used to treat essential tremor after two patients showed sudden improvement after smoking pot or consuming CBD purchased online.

The FDA application outlined the drug formula — a 20:1 ratio of CBD to THC, to minimize any high study participants might feel — as well as its purity, toxicity, shelf life and other details. They also had to get safety approvals from the university and present their plans to a California research advisory panel.

The university is still recruiting patients and hopes to have 16 to 20 enrolled. Researchers monitor the tremors with a device placed on the wrist and will record changes in the severity of the shaking, among other things.

Tilray is providing the drug and limited financial support but said it will have no role in reviewing the study’s results.

“Essential tremor is ten times more common than Parkinson’s and yet nobody really knows about essential tremor,” Nahab said. “That we’re finally getting to a potential therapeutic option in an area that is untapped is a big deal.”

To read more visit: https://newsinfo.inquirer.net/1033910/us-govt-approve-importation-of-pot-drug-for-tremor-study

Is psilocybin next for drug reformers after cannabis legalization?

Congressman Beto O’Rourke (D-TX), a U.S. Senate candidate, delivered fired up comments about marijuana, Botham Jean’s killing by police and the racially discriminatory drug war.

Activists in Denver, Colorado and Oregon took steps this month toward qualifying ballot measures allowing psilocybin use.

California Gov. Jerry Brown (D), who has a history of saying mean-spirited and inaccurate things about people who use cannabis, took a dig at marijuana consumers in an unrelated comment about fighting back against climate change.

  • “We either do nothing and smoke marijuana because it’s legalized, or we put our shoulder to the plow and do everything we can.”

FEDERAL

The Trump administration is organizing a drug policy event outside of this month’s United Nations General Assembly, according to leaked documents.

The Department of Justice convened a meeting in Denver for U.S. attorneys to discuss marijuana policy.

Congresswoman Mia Love (R-UT) said she’s undecided on the state’s medical cannabis ballot measure, while her Democratic challenger supports it.

Congressman Vern Buchanan (R-FL) and his Democratic opponent are taking differing positions on rescheduling marijuana.

Congressman Earl Blumenauer (D-OR) and Congressman Peter DeFazio (D-OR) discussed marijuana policy while sampling CBD-infused beer.

The U.S. Senate bill to encourage the Department of Veterans Affairs to study medical cannabis got one new cosponsor, for a total of five.

The U.S. House bill to protect federal employees from getting fired for state-legal marijuana use got two new cosponsors, for a total of three.

STATES

Here’s an advance look at the details of New Jersey’s soon-to-be-filed marijuana legalization billGov. Phil Murphy (D) supports a higher tax rate than is proposed in the bill, but said he’s “not ruling anything out.”

Colorado Gov. John Hickenlooper (D) spoke about his support for expanding marijuana research.

Utah’s lieutenant governor asked a federal judge to dismiss a lawsuit seeking to remove a medical cannabis initiative from the state’s ballot.

California’s treasurer tweeted, “We’re exploring a public cannabis bank so biz don’t have to operate purely in cash. Carrying around thousands of dollars paints a target on legal biz & increases violence in communities. Until DC takes action, CA will lead on legalized cannabis.”

Missouri appeals court affirmed a judge’s dismissal of a lawsuit that one medical cannabis campaign filed seeking to remove a competing measure from the ballot.

Here’s a look at where Minnesota gubernatorial candidates stand on legalizing marijuana.

Illinois Democratic attorney general candidate Kwame Raoul said he supports legalizing marijuana but wants to regulate edibles.

Alaska regulators certified changes to rules on marijuana advertising and promotions.

Massachusetts regulators will consider granting marijuana retail, cultivation and manufacturing licenses on Thursday.

Here’s a look at where New York is on the path to legalizing marijuana.

LOCAL

Manhattan’s district attorney spoke at a marijuana industry event, saying he wants cannabis entrepreneurs to “be successful and legal.”

The Broken Arrow, Oklahoma City Council adopted ordinances regulating medical cannabis businesses.

INTERNATIONAL

The South African government and lawmakers reacted to a court ruling overturning the prohibition on using and growing marijuana for personal use.

Malaysian Prime Minister Mahathir Mohamad says the death sentence of a man convicted of selling medical cannabis oil should be reviewed.

SCIENCE & HEALTH

A study “demonstrated rapid and durable improvement in social anxiety symptoms in autistic adults following MDMA-assisted psychotherapy.”

A majority of participants in a trial on CBD’s effects on severe epilepsy are seeing improvement in seizures.

OPINION & ANALYSIS

A poll found that Maryland residents support legalizing marijuana, 62% – 33%.

BUSINESS

Aurora Cannabis Inc. addressed reports that it is in talks with the Coca-Cola Company about making CBD beverages together.

CULTURE

Actress Kristen Bell said she likes to vaporize marijuana and watch 60 Minutes.

Comedian Chelsea Handler tweeted, “Coca-Cola is supposedly considering cannabis-infused drinks. Just a reminder: there are still people in prison because of marijuana. Let’s address that first.”

Maine restaurant Charlotte Grill thinks it’s more “humane” to blow marijuana smoke into a box of lobsters before boiling them to death.

To read more visit: https://www.marijuanamoment.net/is-psilocybin-next-for-drug-reformers-after-cannabis-legalization-newsletter-sep-19-2018/

Canada: How will the legalization of cannabis affect athletes? It’s hard to say

While there’s been plenty of discussion around the pending legalization of cannabis, its effect on athletes hasn’t been part of the conversation. One of the reasons for the absence of dialogue is marijuana’s reputation for impairing, not improving athletic performance, which makes cannabis a poor workout partner.

The other reason that athletes have been left out of the discourse is the inclusion of marijuana on the World Anti Doping Association’s (WADA) list of substances banned during the competitive season, thereby limiting its use among elite athletes. Yet despite these factors, marijuana is reported to be the second most popular drug among athletes, after alcohol. It replaces tobacco, which ranks No. 2 among the rest of the population.

Prohibited by WADA for in-season use since 2004, marijuana is considered a “risk to health” of athletes and “in violation of the spirit of sport.” Yet the legalization of cannabis in Canada may lead to a change in how our athletes, both recreational and elite, view marijuana.

“Changing social attitudes and cannabis policies around the world may play an important role in changing use patterns of cannabis among athletes,” said a team of Montreal researchers led by Mark Ware.

Ware, who recently took a leave from his role as associate professor of family medicine and anesthesia at Montreal’s McGill University Health Centre to accept the position of chief medical officer at a medical marijuana company, addressed with his team the issue of cannabis and the health and performance of the elite athlete in a review paper published this month in the Clinical Journal of Sport Medicine.

Getting a clear picture of how marijuana affects performance as well as the pattern of use among athletes isn’t easy. There are ethical issues around getting athletes to participate in studies given the existing laws concerning the use of marijuana as well as those instituted by sporting organizations. And given that the potency of cannabis varies depending on the strain and how it’s used and that much of the data compiled in studies as early as a decade ago may reflect a substance far different from the one sold today, there’s some question about the veracity of the information we do have.

In the meantime what we do know is that cannabis use increases heart rate and blood pressure while reducing physical work capacity, none of which are conditions consistent with winning gold.  As such, it’s unlikely that athletes use cannabis with the expectation that it’s going to result in an immediate boost in performance. Instead its use is likely related to its secondary affects. Marijuana has been used to ameliorate pain and concussion symptoms, improve sleep, spark appetite and reduce the stress associated with competing at the elite level.

“Self-reported use of cannabis for pain and concussion management among elite athletes is increasingly being reported,” said the Montreal research team.

Also reported by a separate team of researchers is that athletes involved in individual sports such as snowboarding, skiing, surfing, sailing and kayaking are more likely to use marijuana than team sport athletes.

Yet despite how athletes regard marijuana, the Canadian Centre for Ethics in Sport is clear that it will continue to be prohibited during competition even after legalization. To help clear up any confusion, they have published a Cannabis in Sport information guide geared to elite athletes subject to drug testing and doping violations.

Still, Ware believes that legalization creates conditions that are ripe for more research on the use of marijuana within the athletic community. That said, there are safety considerations worthy of acknowledgement. Recreational users have been known to experience deficits in memory, coordination and judgment and chronic use in youth is thought to have long-term negative consequences. Episodes of paranoia and/or psychosis have also been linked to high doses of cannabis, hence WADA’s concerns regarding the safety of athletes who use the drug.

Ware hopes that given concerns about safety and the changing views and laws on marijuana, the opportunity to find out more about the real world use of cannabis within the athletic community shouldn’t be ignored.

“Legalization (of marijuana) allows us to have more honest and open conversations with athletes,” said Ware.

Those conversations, combined with more targeted research on how marijuana use impacts athletes, could lead to more evidence-based information so that athletes of all ages and abilities can make informed choices about how cannabis affects their training and performance. Athletes, like the rest of the country, need information based in science, not assumption, regarding the recreational and medical use of cannabis given its new legal status.

Until we know more about marijuana, athletes are warned that in-season use could lead to a doping violation. And for recreational athletes, the knowledge that cannabis impairs physical and mental capacity over the short term means that caution should be taken when it comes to use prior to training or a workout.

To read more visit: https://420intel.com/articles/2018/09/19/canada-how-will-legalization-cannabis-affect-athletes-its-hard-say

Cannabis 101: A guide to CBD oil, what it is, how it works, who can use it

This is part of an on-going series of Sun-Times info guides about cannabis. Today, we look at CBD oil: what it is; how it works; what it treats plus the legal issues surrounding CBD use in Illinois.

Cannabidiol, or CBD, is a non-intoxicationg chemical compound that comes from the cannabis sativa plant.  CBD is one of over 100 such compounds, known as cannabinoids, that are found in the plant.

Unlike THC — or tetrahydrocannabinol, another cannabinoid — CBD doesn’t get users stoned. In recent years, CBD has grown increasingly popular, with patients and experts reporting that it can be used to treat a range of health conditions, including epilepsyCrohn’s disease and even anxiety in dogs.

Here’s everything you need to know about the trendy drug treatment:

What is the history of CBD?

CBD was first discovered in the 1940s by Roger Adams, the former head of the chemistry department at University of Illinois at Champaign-Urbana. In his research, Adams isolated CBD from hemp but couldn’t determine what exactly he’d found. In addition to CBD, Adams also synthesized analogs of THC and another cannabinoid, showing their relationship to CBD.

In the 1960s, Israeli chemist Raphael Mechoulam and his team took the research further, eventually synthesizing cannabinoids — including CBD, THC and others — and describing their chemical structures for future research. Mechoulam, a professor at Hebrew University of Jerusalem, still studies cannabis to this day.

Is CBD legal in Illinois?

Much of the confusion over CBD stems from its murky legal status.

Because the DEA still lists hemp and marijuana as dangerous Schedule I drugs, along with heroin and ecstasy, CBD remains illegal under federal law. Congress is now is considering the 2018 Farm Bill, which would legalize industrial hemp across the country.

Despite some confusion, the Agriculture Act of 2014 didn’t legalize hemp-based CBD products nationwide, but only allowed for states and universities to grow hemp. Nevertheless, hemp-based CBD is already widely and freely available throughout most of the country.

Illinois is among 37 states that have legalized marijuana-based CBD for medical use, while nine other states have fully legalized pot and its derivatives. Four other states — Idaho, Kansas, Nebraska and South Dakota — still prohibit the medical use of pot-based CBD.

Last month, Illinois Gov. Bruce Rauner signed off on a bill that legalized industrial hempcultivation in Illinois and established rules to test crops’ THC levels. Like the bill being considered by federal lawmakers, the legislation in Illinois bars hemp-based CBD from containing more than 0.3 percent THC.

What is CBD used to treat?

In a study released last year, the World Health Organization’s Expert Committee on Drug Dependence said CBD may benefit people diagnosed with:

  • Alzheimer’s disease
  • Parkinson’s disease
  • Multiple sclerosis
  • Huntington’s disease
  • Pain
  • Psychosis
  • Anxiety
  • Depression
  • Cancer
  • Nausea
  • Inflammatory diseases
  • Rheumatoid arthritis
  • Infection
  • Inflammatory bowel and Crohn’s disease
  • Cardiovascular diseases
  • Diabetic complications

In the report, the committee noted that “CBD exhibits no effects indicative of any abuse or dependence potential.” Other health care professionals are also using CBD to treat other medical issues, like autism, sleep problems and other mental health conditions.

CBD started gaining national exposure when media outlets began profiling Charlotte Figi, an 11-year-old girl from Colorado with Dravet syndrome, a severe form of intractable epilepsy.

At age 5, Figi’s parents, Matt and Paige Figi, had exhausted all traditional options in their quest to control the hundreds of grand mal seizures their young daughter was experiencing every day. They ultimately turned to the Stanleys, a group of brothers who grow pot in Colorado, who then developed a groundbreaking hemp-based CBD oil they dubbed “Charlotte’s Web.”

Since she began taking the oil, Figi has experienced far fewer seizures and is able to enjoy a more normal childhood. However, evidence from cases like Figi’s remains largely anecdotal as researchers continue to pin down CBD’s exact scientific effects. 

What are the effects of CBD?

Unlike THC, CBD doesn’t get users high, an important distinction that has helped drive the popularity of the drug compound.

Traditional medications tend to target the symptoms of a specific condition, but CBD goes after the cause of those symptoms, according to Ronald Aung-Din, M.D., a renowned Florida neurologist.

Pharmaceuticals generally stimulate or block receptors to provide their function, but CBD and other cannabis-based treatments interact with the body’s endocannabinoid system, which naturally binds to chemicals like CBD and THC. This biological effect reportedly enables CBD to treat such a wide range of medical conditions.

A European study published last year by the National Center for Biotechnical Information listed tiredness, diarrhea and changes in weight and appetite as possible side effects of CBD. Most of the research was conducted on patients with epilepsy or psychotic disorders.

Are there different types of CBD?

Yes, there are several different types including:

Marijuana-based CBD:

CBD products that come from the marijuana plant tend to have higher amounts of THC, a combination that some experts claim increases the CBD’s healing effects. As a result, CBD strains with higher amounts of THC can cause both euphoria and stony side effects, like anxiety, paranoia and dizziness, according to Leafly.

To buy marijuana-derived CBD from an Illinois dispensary, qualifying patients must first obtain a medical cannabis card by following the steps outlined in this Sun-Times guide to medical marijuana in Illinois.

Once a patient has been approved for the state’s medical program, they can go to the dispensary they selected during the application process to buy CBD and other cannabis products.

Hemp-Based CBD:

Hemp-based CBD products can be bought over-the-counter at wellness centers and bong shops in most of America, including Illinois.

There are a pair of options for hemp-based CBD users: Products that only contain CBD and others that contain a full range of hundreds of cannabinoids, including cannabinol (CBN), cannabigerol (CBG) and tetrahydrocannabivarin (THCV), as well as CBD and a minuscule amount of THC.

All the different chemicals found in the cannabis plant are said to have various healing effects. For example, non-intoxicating CDG apparently helps with sleep and inflammation and kills bacteria.

A new study predicts the market for hemp-derived CBD could eclipse the rest of the legal pot industry to reach $22 billion by 2022. 

Pharmaceutical CBD:

In June, the U.S. Food and Drug Administration approved the first prescription CBD drug, a move that will almost undoubtedly spur more research into what else it can treat. 

The drug, a strawberry-flavored syrup called Epidiolex, is used to treat two rare forms of childhood epilepsy. During their research, FDA officials found that Epidiolex reduced seizures when it was combined with other epilepsy drugs.

FDA Commissioner Scott Gottlieb said his agency had supported research on cannabis-derived products for “many years,” but warned against the use of CBD products with “unproven medical claims.”

“The promotion and use of these unapproved products may keep some patients from accessing appropriate, recognized therapies to treat serious and even fatal diseases,” Gottlieb said.

Before Epidiolex can go to market, the Drug Enforcement Administration must formally reclassify CBD into a federal drug category with medical approval. The FDA has previously approved synthetic cannabinoids to treat severe weight loss in patients with HIV.

To read more visit: https://chicago.suntimes.com/cannabis/cannabis-cdb-oil-medical-marijuana-guide/

Want to buy legal pot on Oct. 17? Here’s what you need to know

With just a month left to go until recreational pot is legal across the country, here’s what you need to know if you want to partake.

Where can I get some of that legal weed?

On Oct. 17, there will be just one B.C. Cannabis Store in the entire province. The government shop will be located in Kamloops at the Columbia Place Shopping Centre. There will also be online sales through the B.C. Liquor Distribution Branch.

What about all those private dispensaries in cities like Vancouver?

There’s no indication these will be shut down right away. The province’s new Community Safety Unit has pledged a crackdown, but only after more legal outlets are available.

The B.C. government says it’s received more than 100 applications for retail shops across the province. It’s possible some of those could be approved in time for Oct. 17.

In Vancouver, which began licensing illegal pot dispensaries in 2015, pot shops will need a development permit, a provincial retail licence and a new municipal business licence if they want to stay open.

Who’s allowed to partake?

Like alcohol, the minimum age for possession has been set at 19. But unlike liquor stores, anyone under the age of 19 is banned from entering a cannabis dispensary, even if they’re with an adult.

What can I buy?

For now, only dried cannabis, seeds and oils will be legally available, along with accessories like rolling papers, pipes and bongs.

What about edibles?

All those pot-infused brownies and cookies will still be illegal on Oct. 17. The plan is for legal edibles to be available within a year.

And vaping?

Cannabis concentrates and vape juice won’t be legal on Oct. 17, either. Health Canada says it needs more evidence about the risks.

How much pot am I allowed to have?

Adults can possess up to 30 grams of weed in public places, and grow as many as four plants per household — as long as the home isn’t being used as a daycare. Those plants must not be visible from public spaces.

Vaping is not just for tobacco. In California, nearly a quarter of sales from 2016 were for cannabis vape cartridges.

Where can I smoke up?

Toking will be banned everywhere that cigarette smoking is, as well as in vehicles, and places where children commonly gather, including school properties, playgrounds, sports fields and skate parks.

What are the potential penalties for breaking those rules?

Selling cannabis to minors will still be a federal crime, punishable by up to 14 years in jail. B.C. has also introduced some new cannabis offences, with fines ranging from $2,000 to $100,000 and jail time of three to 12 months.

What are the restrictions around driving?

Anyone in the graduated licensing program won’t be allowed to have any THC in their system. For everyone else, the province says it’s giving police “specialized training” and tools to identify drugged drivers. Potential penalties include a 90-day driving ban.

Both drivers and passengers are prohibited from smoking inside vehicles.

To read more visit: https://420intel.ca/articles/2018/09/19/want-buy-legal-pot-oct-17-heres-what-you-need-know